8 HR Carbidopa 23.75 MG / L-DOPA 95 MG Extended Release Oral Capsule

RxCUI: 1600773
RxNorm name: 8 HR Carbidopa 23.75 MG / L-DOPA 95 MG Extended Release Oral Capsule
Display name: 8 HR Carbidopa 23.75 MG / L-DOPA 95 MG Extended Release Oral Capsule
Full name: 8 HR Carbidopa 23.75 MG / L-DOPA 95 MG Extended Release Oral Capsule
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Carbidopa and Levodopa	CARBIDOPA AND LEVODOPA	REMEDYREPACK INC.	beedd327-bbc5-4f17-838a-4e72bf0867f0	2026-04-24	Warnings, Adverse reactions	Exact identifier rxcui: 1600773
RYTARY	CARBIDOPA AND LEVODOPA	Amneal Pharmaceuticals LLC	6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7	2026-03-26	Warnings, Adverse reactions	Exact identifier rxcui: 1600773
Carbidopa and Levodopa	CARBIDOPA AND LEVODOPA	Zydus Pharmaceuticals USA Inc.	74e7f96b-de31-4e3c-b32d-11421b291d4e	2025-11-14	Warnings, Adverse reactions	Exact identifier rxcui: 1600773

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7	8 HR Carbidopa 23.75 MG / L-DOPA 95 MG Extended Release Oral Capsule	SY	26	These highlights do not include all the information needed to use RYTARY safely and effectively. See full prescribing information for RYTARY. RYTARY (carbidopa and levodopa) extended-release capsules, for oral use Initial U.S. Approval: 1975	20260326
6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7	carbidopa 23.75 MG / levodopa 95 MG 8HR Extended Release Oral Capsule	PSN	26	These highlights do not include all the information needed to use RYTARY safely and effectively. See full prescribing information for RYTARY. RYTARY (carbidopa and levodopa) extended-release capsules, for oral use Initial U.S. Approval: 1975	20260326
6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7	carbidopa 23.75 MG / levodopa 95 MG 8 HR Extended Release Oral Capsule	SY	26	These highlights do not include all the information needed to use RYTARY safely and effectively. See full prescribing information for RYTARY. RYTARY (carbidopa and levodopa) extended-release capsules, for oral use Initial U.S. Approval: 1975	20260326
6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7	8 HR carbidopa 23.75 MG / levodopa 95 MG Extended Release Oral Capsule	SCD	26	These highlights do not include all the information needed to use RYTARY safely and effectively. See full prescribing information for RYTARY. RYTARY (carbidopa and levodopa) extended-release capsules, for oral use Initial U.S. Approval: 1975	20260326
74e7f96b-de31-4e3c-b32d-11421b291d4e	carbidopa 23.75 MG / levodopa 95 MG 8 HR Extended Release Oral Capsule	SY	2	These highlights do not include all the information needed to use CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES. CARBIDOPA and LEVODOPA extended-release capsules, for oral use Initial U.S. Approval: 1975	20251114
74e7f96b-de31-4e3c-b32d-11421b291d4e	8 HR carbidopa 23.75 MG / levodopa 95 MG Extended Release Oral Capsule	SCD	2	These highlights do not include all the information needed to use CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES. CARBIDOPA and LEVODOPA extended-release capsules, for oral use Initial U.S. Approval: 1975	20251114
74e7f96b-de31-4e3c-b32d-11421b291d4e	8 HR Carbidopa 23.75 MG / L-DOPA 95 MG Extended Release Oral Capsule	SY	2	These highlights do not include all the information needed to use CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES. CARBIDOPA and LEVODOPA extended-release capsules, for oral use Initial U.S. Approval: 1975	20251114
74e7f96b-de31-4e3c-b32d-11421b291d4e	carbidopa 23.75 MG / levodopa 95 MG 8HR Extended Release Oral Capsule	PSN	2	These highlights do not include all the information needed to use CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES. CARBIDOPA and LEVODOPA extended-release capsules, for oral use Initial U.S. Approval: 1975	20251114
beedd327-bbc5-4f17-838a-4e72bf0867f0	8 HR carbidopa 23.75 MG / levodopa 95 MG Extended Release Oral Capsule	SCD	1	These highlights do not include all the information needed to use CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES. CARBIDOPA and LEVODOPA extended-release capsules, for oral use Initial U.S. Approval: 1975	20260424
beedd327-bbc5-4f17-838a-4e72bf0867f0	carbidopa 23.75 MG / levodopa 95 MG 8HR Extended Release Oral Capsule	PSN	1	These highlights do not include all the information needed to use CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES. CARBIDOPA and LEVODOPA extended-release capsules, for oral use Initial U.S. Approval: 1975	20260424
beedd327-bbc5-4f17-838a-4e72bf0867f0	carbidopa 23.75 MG / levodopa 95 MG 8 HR Extended Release Oral Capsule	SY	1	These highlights do not include all the information needed to use CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES. CARBIDOPA and LEVODOPA extended-release capsules, for oral use Initial U.S. Approval: 1975	20260424
beedd327-bbc5-4f17-838a-4e72bf0867f0	8 HR Carbidopa 23.75 MG / L-DOPA 95 MG Extended Release Oral Capsule	SY	1	These highlights do not include all the information needed to use CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for CARBIDOPA AND LEVODOPA EXTENDED-RELEASE CAPSULES. CARBIDOPA and LEVODOPA extended-release capsules, for oral use Initial U.S. Approval: 1975	20260424